Companies / Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

Nasdaq: OLMACIK 1750284SAN FRANCISCO, CA

Financials

Revenue—
Net income$-162.45M
Total debt—
Cash$48.60M
Diluted EPS$-1.87
Shares outstanding87.5M

Ownership

87.5M shares outstanding · as of Aug 6, 2026
1.8%Insiders
Ownership
Insiders1.80%1,571,525
10%+ / strategic11.43%9,998,060
Institutions103.94%90,942,992
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 20

View all →
Insider% of sharesShares
Harmon CyrusDirector
0.83%727,770
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF
0.79%687,607
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.
0.16%139,727
Austin Sasha LuVP of Finance and Controller
0.02%16,188
Mitchell ShawnteCHIEF LEGAL OFFICER
<0.01%233
Biotechnology Value Fund II LPDirector
——
Biotechnology Value Fund L PDirector
——
Biotechnology Value Trading Fund OS LPDirector
——
Bohen SeanCEOPRESIDENT AND CEO · Director
——
Butitta Cynthia MDirector
——

Institutional holders 210

View all →
HolderValue% of shares
Bain Capital Life Sciences Investors, LLC$212.72M9.72%
Paradigm BioCapital Advisors LP$188.60M8.62%
Fmr LLC$125.58M5.74%
Janus Henderson Group PLC$106.01M8.12%
Vanguard Group Inc$89.03M4.07%
BlackRock, Inc.$84.00M7.67%
Siren, L.L.C.$82.52M3.77%
Logos Global Management LP$80.22M3.67%
Bvf INC/IL$78.96M6.05%
Cormorant Asset Management, LP$68.75M3.14%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 15, 2026Kovacs Shane William Charles
Executive
SellCommon Stock$2.87M-100K
-41.71%
139,727
0.16% of shares
medium
Jan 13, 2026Myles David C.
Executive
SellCommon Stock$1.37M-50K
-8.40%
542,961
0.62% of shares
medium
Jan 14, 2026Myles David C.
Executive
SellCommon Stock$1.01M-35K
-6.06%
542,761
0.62% of shares
medium
Mar 4, 2026Mitchell Shawnte
Executive
SellCommon Stock$600.6K-25K
-99.07%
233
<0.01% of shares
medium
Jan 14, 2026Myles David C.
Executive
SellCommon Stock$428.9K-15K
-2.53%
577,764
0.66% of shares
medium
Mar 3, 2026Mitchell Shawnte
Executive
SellCommon Stock$345.1K-15K
-100.00%
0
0.00% of shares
medium
Jan 12, 2026Myles David C.
Executive
SellCommon Stock$283.4K-10K
-6.46%
144,846
0.17% of shares
medium
Jan 20, 2026Harmon Cyrus
Director
SellCommon Stock$268.8K-10K
-1.36%
727,770
0.83% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Janus Henderson Group PLCPassive13G/A———
Deep Track Capital, LPPassive13G/A—0—
Bain Capital Life Sciences Opportunities IV, L.P.Passive13G/A———
Fmr LLCPassive13G/A—9,998,060—
Fmr LLCPassive13G—5,023,092—
Invus, L.P.Passive13G———
Janus Henderson Group PLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OLMA——68062P106—